Prevalence of duchenne and becker muscular dystrophies in the United States

Pediatrics

Volumn 135, Issue 3, 2015, Pages 513-521

  Romitti, Paul A ^a   Zhu, Yong ^a   Puzhankara, Soman ^a   James, Katherine A ^b   Nabukera, Sarah K ^a   Zamba, Gideon K D ^a   Ciafaloni, Emma ^c   Cunniff, Christopher ^d   Druschel, Charlotte M ^e,f   Mathews, Katherine D ^a   Matthews, Dennis J ^b   Meaney, F John ^d   Andrews, Jennifer G ^d   Caspers Conway, Kristin M ^a   Fox, Deborah J ^e   Street, Natalie ^g   Adams, Melissa M ^g   Bolen, Julie ^g  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^f STATE UNIVERSITY OF NEW YORK   (United States)

^g NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BECKER MUSCULAR DYSTROPHY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CULTURAL FACTOR; DISEASE SURVEILLANCE; DUCHENNE MUSCULAR DYSTROPHY; ETHNICITY; HUMAN; LONGITUDINAL STUDY; MALE; OUTCOME ASSESSMENT; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SOCIOECONOMICS; UNITED STATES; CLINICAL TRIAL; EPIDEMIOLOGY; ETHNIC GROUP; ETHNOLOGY; FEMALE; HEALTH SURVEY; MULTICENTER STUDY; RETROSPECTIVE STUDY;

CHILD; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; FEMALE; HUMANS; MALE; MUSCULAR DYSTROPHY, DUCHENNE; POPULATION SURVEILLANCE; PREVALENCE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84924308432     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-2044     Document Type: Article

References (48)

1. Ballo R, Viljoen D, Beighton P. Duchenne and Becker muscular dystrophy prevalence in South Africa and molecular findings in 128 persons affected. S Afr Med J. 1994;84(8 pt 1): 494-497
2. Chung B, Wong V, Ip P. Prevalence of neuromuscular diseases in Chinese children: a study in southern China. J Child Neurol. 2003;18(3):217-219
3. Nakagawa M, Nakahara K, Yoshidome H, et al. Epidemiology of progressive muscular dystrophy in Okinawa, Japan. Classification with molecular biological techniques. Neuroepidemiology. 1991; 10(4):185-191
4. Peterlin B, Zidar J, Meznaric-Petrusa M, Zupancic N. Genetic epidemiology of Duchenne and Becker muscular dystrophy in Slovenia. Clin Genet. 1997; 51(2):94-97
5. Monckton G, Hoskin V, Warren S. Prevalence and incidence of muscular dystrophy in Alberta, Canada. Clin Genet. 1982;21(1):19-24
6. Norwood FLM, Harling C, Chinnery PF, et al. Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain. 2009;132(pt 11):3175-3186
7. Darin N, Tulinius M. Neuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden. Neuromuscul Disord. 2000; 10(1):1-9
8. Kanamori M, Morton NE, Fujiki K, Kondo K. Genetic epidemiology of Duchenne muscular dystrophy in Japan: classical segregation analysis. Genet Epidemiol. 1987;4(6):425-432
9. Yasuda N, Kondô K. No sex difference in mutations rates of Duchenne muscular dystrophy. J Med Genet. 1980;17(2): 106-111
10. Morton NE, Chung CS. Formal genetics of muscular dystrophy. Am J Hum Genet. 1959;11(4):360-379
11. Hauser E, Toifl K, Mad A, Bittner R. The incidence of Duchenne muscular dystrophy in eastern Austria. The controversy regarding CK screening. Wien Klin Wochenschr. 1993;105(15): 433-436
12. Leth A, Wulff K, Corfitsen M, Elmgreen J. Progressive muscular dystrophy in Denmark. Natural history, prevalence and incidence. Acta Paediatr Scand. 1985;74(6):881-885
13. Jeppesen J, Green A, Steffensen BF, Rahbek J. The Duchenne muscular dystrophy population in Denmark, 1977-2001: prevalence, incidence and survival in relation to the introduction of ventilator use. Neuromuscul Disord. 2003;13(10):804-812
14. Talkop UA, Kahre T, Napa A, et al. A descriptive epidemiological study of Duchenne muscular dystrophy in childhood in Estonia. Eur J Paediatr Neurol. 2003;7(5):221-226
15. van Essen AJ, Busch HFM, te Meerman GJ, ten Kate LP. Birth and population prevalence of Duchenne muscular dystrophy in The Netherlands. Hum Genet. 1992;88(3):258-266
16. Prot J. Genetic-epidemiological studies in progressive muscular dystrophy. J Med Genet. 1971;8(1):90-95
17. Hughes MI, Hicks EM, Nevin NC, Patterson VH. The prevalence of inherited neuromuscular disease in Northern Ireland. Neuromuscul Disord. 1996;6(1): 69-73
18. Merlini L, Stagni SB, Marri E, Granata C. Epidemiology of neuromuscular disorders in the under-20 population in Bologna Province, Italy. Neuromuscul Disord. 1992;2(3):197-200
19. Bundey S. A genetic study of Duchenne muscular dystrophy in West Midlands. J Med Genet. 1981;18(1):1-7
20. Mah JK, Kornqut L, Dykeman J, et al. A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscul Disord. 2014;24(6): 482-491
21. Manzur AY, Kuntzer T, Pike M, Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev. 2008; (1):CD003725
22. Eagle M, Baudouin SV, Chandler C, et al. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord. 2002;12(10): 926-929
23. Bach JR. A historical perspective on the use of noninvasive ventilatory support alternatives. Respir Care Clin N Am. 1996; 2(2):161-181
24. Yasuma F, Konagaya M, Sakai M, et al. A new lease on life for patients with Duchenne muscular dystrophy in Japan. Am J Med. 2004;117(5):363
25. Eagle M, Bourke J, Bullock R, et al. Managing Duchenne muscular dystrophy - the additive effect of spinal surgery and home nocturnal ventilation in improving survival. Neuromuscul Disord. 2007;17(6):470-475
26. Birnkrant DJ, Noritz GH. Is there a role for palliative care in progressive pediatric neuromuscular diseases? The answer is "Yes!" J Palliat Care. 2008; 24(4):265-269
27. Bothwell JE, Dooley JM, Gordon KE, et al. Duchenne muscular dystrophy - parental perceptions. Clin Pediatr (Phila). 2002;41(2):105-109
28. Chen JY, Clark MJ. Family function in families of children with Duchenne muscular dystrophy. Fam Community Health. 2007;30(4):296-304
29. Romitti P, Puzhankara S, Mathews K, et al; Centers for Disease Control and Prevention (CDC). Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years - four states, 2007. MMWR Morb Mortal Wkly Rep. 2009;58(40):1119-1122
30. Lubs ML. Hemophilia A and Duchenne muscular dystrophy in Colorado. Am J Hum Genet. 1974;26(6):56A
31. Miller LA, Romitti PA, Cunniff C, et al. The Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): surveillance methodology. Birth Defects Res A Clin Mol Teratol. 2006;76(11):793-797
32. Mathews KD, Cunniff C, Kantamneni JR, et al. Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): case definition in surveillance for childhood-onset Duchenne/Becker muscular dystrophy. J Child Neurol. 2010;25(9):1098-1102
33. Ciafaloni E, Fox DJ, Pandya S, et al. Delayed diagnosis in Duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). J Pediatr. 2009;155(3):380-385
34. Samaha FJ, Quinlan JG. Dystrophinopathies: clarification and complication. J Child Neurol. 1996;11(1): 13-20
35. Nabukera SK, Romitti PA, Campbell KA, et al; MD STARnet. Use of complementary and alternative medicine by males with Duchenne or Becker muscular dystrophy. J Child Neurol. 2012;27(6): 734-740
36. Nabukera SK, Romitti PA, Caspers KM, et al; MD STARnet. Reproductive patterns among mothers of males diagnosed with Duchenne or Becker muscular dystrophy. Am J Med Genet A. 2013; 161A(1):70-75
37. O'Hare WP. Assessing net coverage error for young children in the 2010 US decennial census. US Census Bureau Center for Survey Measurement Study Series. Available at: www.census.gov/srd/papers/pdf/ssm2014-02.pdf. Accessed October 21, 2014
38. United States Census 2010. Available at: www.census.gov/2010census/. Accessed February 3, 2014
39. Ahlström G, Gunnarsson LG, Leissner P, Sjödén PO. Epidemiology of neuromuscular diseases, including the postpolio sequelae, in a Swedish county. Neuroepidemiology. 1993;12(5): 262-269
40. Kvasnicová M, Styková J, Hudec P. Incidence of spinal muscular atrophy and Duchenne's muscular dystrophy in the juvenile population of central Slovakia [in Slovak]. Bratisl Lek Listy (Tlacene Vyd). 1994;95(2):78-82
41. Dooley J, Gordon KE, Dodds L, MacSween J. Duchenne muscular dystrophy: a 30-year population-based incidence study. Clin Pediatr (Phila). 2010;49(2):177-179
42. Bushby KMD, Thambyayah M, Gardner- Medwin D. Prevalence and incidence of Becker muscular dystrophy. Lancet. 1991;337(8748):1022-1024
43. El-Tallawy HN, Khedr EM, Qayed MH, et al. Epidemiological study of muscular disorders in Assiut, Egypt. Neuroepidemiology. 2005;25(4): 205-211
44. Mostacciuolo ML, Miorin M, Pegoraro E, et al. Reappraisal of the incidence rate of Duchenne and Becker muscular dystrophies on the basis of molecular diagnosis. Neuroepidemiology. 1993; 12(6):326-330
45. Siciliano G, Tessa A, Renna M, et al. Epidemiology of dystrophinopathies in North-West Tuscany: a molecular genetics-based revisitation. Clin Genet. 1999;56(1):51-58
46. Holmgren J, Reyes J, Colombo M, Blanco MA. Duchenne and Becker muscular dystrophy in Chile [in Spanish]. Rev Med Chil. 1992;120(3):288-292
47. Helderman-van den Enden ATJM, Madan K, Breuning MH, et al. An urgent need for a change in policy revealed by a study on prenatal testing for Duchenne muscular dystrophy. Eur J Hum Genet. 2013;21(1): 21-26
48. Zhu Y, Romitti PA, Conway KM, et al. Complementary and alternative medicine for Duchenne and Becker muscular dystrophies: characteristics of users and caregivers. Pediatr Neurol. 2014;51(1):71-77